Search Results 1-10 of 16462 for Huntington's+disease

  1. Huntington's disease - Symptoms and causes - Mayo Clinic

    This rare disease causes an early decay of nerve cells in the brain. Learn about its symptoms and how treatments may help.

  2. Huntington's disease - Diagnosis and treatment - Mayo Clinic

    Diagnosis · Neurological exam · Neuropsychological testing · Mental health evaluation · Brain-imaging and function tests · Genetic counseling and testing · Predictive ...

  3. Parkinson's disease - Diagnosis and treatment - Mayo Clinic

    This test, also called an alpha-synuclein seed amplification assay, detects Parkinson's disease before symptoms begin. Alpha-synuclein clumps are a hallmark ...

  4. Huntington's disease - Care at Mayo Clinic

    Advanced diagnosis and treatment. Mayo Clinic doctors have expertise and experience in evaluating and treating people with Huntington's disease and other ...

  5. Hematology - Clinical trials

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory aggressive B- ...

  6. A Study to Investigate the Long Term Safety, Tolerability And Effectiveness of Pf-02545920 in Subjects with Huntington's Disease Who Completed Study A8241021 - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  7. Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease - Mayo Clinic

    Primary endpoint is the change from baseline in the Total Motor Score (TMS) assessment of the Unified Huntington Disease Rating Scale (UHDRS) after 26 weeks of ...

  8. Hematology - Clinical trials

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...

  9. A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Subjects With Select Advanced Malignancies - Mayo Clinic

    A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in ...

  10. Hematology - Clinical trials

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...